Chosun University Hospital Receives Grade 1 in '2020 Drug Benefit Appropriateness Evaluation'

[Asia Economy Honam Reporting Headquarters Reporter Yoon Jamin] Chosun University Hospital (Director Jeong Jong-hoon) announced on the 21st that it received a 'Grade 1' rating in the antibiotic prescription rate and injection prescription rate categories of the Health Insurance Review and Assessment Service's '2020 Drug Benefit Appropriateness Evaluation.'

The HIRA has been conducting the Drug Benefit Appropriateness Evaluation since 2001 to analyze prescriptions of major drugs that have a significant impact on public health, aiming to reduce drug misuse and promote appropriate use to improve national health.

This evaluation was conducted on outpatient prescription drugs, both inpatient and outpatient, from January to December of last year.

Chosun University Hospital achieved Grade 1 with an 'Upper respiratory infection antibiotic prescription rate' of 2.43% (national average 36.06%), 'Lower respiratory infection antibiotic prescription rate' of 33.96% (national average 57.69%), and 'Injection prescription rate' of 1.82% (national average 14.1%).

The hospital demonstrated appropriate drug prescribing by recording usage rates significantly lower than the national average.

Director Jeong Jong-hoon stated, “We will continue to monitor to prevent drug misuse and strive to ensure that antibiotics and injections are prescribed only to patients who truly need them.”

This content was produced with the assistance of AI translation services.